chitosan has been researched along with Hepatic Encephalopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Mokaddem, AK; El-Maadawy, WH; El-Shiekh, RA; Eliwa, HA; Hassan, M; Khalil, HMA; Khalil, IA; Tawfek, AM | 1 |
| Chen, L; Ge, Y; He, H; Li, X; Li, Z; Liu, Y; Luo, X; Ma, W; Qi, W; Wang, N; Wang, X; Zhang, T | 1 |
2 other study(ies) available for chitosan and Hepatic Encephalopathy
| Article | Year |
|---|---|
Ashwagandha-loaded nanocapsules improved the behavioral alterations, and blocked MAPK and induced Nrf2 signaling pathways in a hepatic encephalopathy rat model.
Topics: Animals; Chitosan; Hepatic Encephalopathy; Nanocapsules; Neuroprotective Agents; Plant Extracts; Rats; Signal Transduction; Tissue Distribution | 2023 |
Ameliorative Effect of Chitosan Oligosaccharides on Hepatic Encephalopathy by Reshaping Gut Microbiota and Gut-Liver Axis.
Topics: Ammonia; Animals; Chitosan; DNA, Ribosomal; Gastrointestinal Microbiome; Hepatic Encephalopathy; Oligosaccharides; Rats; Rats, Wistar; Thioacetamide | 2022 |